May 26, 2024

Mounjaro is displayed in a pharmacy

Image: George Frey (Reuters)

Eli Lilly, the world’s most valuable pharmaceutical company, can’t keep up with soaring demand of its popular diabetes and weight loss drugs. The Food and Drug Administration updated its drug shortage database to include most doses of the pharma giant’s Mounjaro and Zepbound. The agency said all doses except for 2.5 milligram injections of each medication will be in limited supply through the second quarter of the year, due to increased demand.

Read More

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *